Skip to content

HDAC Inhibitors as Epigenetic Regulators

HDAC Inhibitor

Day: February 18, 2022

  • Home
  • 2022
  • February
  • 18
  • p60c-src
 Posted on February 18, 2022

In contrast to its proto-oncogenic counterpart c-ABL, BCR-ABL displays constitutive tyrosine kinase activity

In contrast to its proto-oncogenic counterpart c-ABL, BCR-ABL displays constitutive tyrosine kinase activity.1 The ATP-competitive BCR-ABL tyrosine kinase inhibitor imatinib…

In contrast to its proto-oncogenic counterpart c-ABL, BCR-ABL displays constitutive tyrosine kinase activity Read More

Recent Posts

  • == Pathways and biological features connected with EZH2 focus on genes in GC B cells Each row of data corresponds to a pathway or function enriched among EZH2 target genes in GC B cells
  • Thus, the 1st and third transmembrane sections of the 4th domain screen ER-localization activity
  • The protein levels of MKP1 in the lysates were quantified by SDS-PAGE/Western blotting (28) using a commercial antibody for the phosphatase (sc-1109, Santa Cruz Biotech, Santa Cruz, CA)
  • No additional reagent tested was effective, including ab13536 (Abcam)[18], even though the Mathematics5 protein were massively overexpressed
  • Fig

Recent Comments

  • A WordPress Commenter on Hello world!
eCommerce Plus Theme